title: Fundamental study on the implantable LH-RH agonist/polymer and its use in a randomized trial for prostate cancer.
authors.affiliation: Department of Urology, Gunma University School of Medicine.
authors.forename: H
authors.initials: H
authors.lastname: Yamanaka
authors.forename: K
authors.initials: K
authors.lastname: Imai
authors.forename: T
authors.initials: T
authors.lastname: Mashimo
authors.forename: H
authors.initials: H
authors.lastname: Yuasa
authors.forename: M
authors.initials: M
authors.lastname: Yoshida
authors.forename: M
authors.initials: M
authors.lastname: Asano
authors.forename: H
authors.initials: H
authors.lastname: Fukuzaki
authors.forename: M
authors.initials: M
authors.lastname: KumaKura
mesh_terms: D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004343:Drug Implants; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D007773:Lactates; D019344:Lactic Acid; D008297:Male; D011091:Polyesters; D011108:Polymers; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D051381:Rats; D011919:Rats, Inbred Strains; D011966:Receptors, LHRH / Q000187:drug effects*; D005641:Tegafur / Q000008:administration & dosage; D014498:Uracil / Q000008:administration & dosage
chemical_list: D004343:Drug Implants; D007773:Lactates; D011091:Polyesters; D011108:Polymers; D011966:Receptors, LHRH; D005641:Tegafur; D019344:Lactic Acid; C033616:poly(lactide); D014498:Uracil